Discrepancy between disease activity and levels of vascular endothelial growth factor in a patient with POEMS syndrome successfully treated with autologous stem-cell transplantation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
http://www.nature.com/articles/bmt2008223.pdf
Reference12 articles.
1. Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 1998; 21: 1390–1397.
2. Badros A, Porter N, Zimrin A . Bevacizumab therapy for POEMS syndrome. Blood 2005; 106: 1135.
3. Kanai K, Kuwabara S, Misawa S, Hattori T . Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Intern Med 2007; 46: 311–313.
4. Samaras P, Bauer S, Stenner-Liewen F, Steiner R, Zweifel M, Renner C et al. Treatment of POEMS syndrome with bevacizumab. Haematologica 2007; 92: 1438–1439.
5. Straume O, Bergheim J, Ernst P . Bevacizumab therapy for POEMS syndrome. Blood 2006; 107: 4972–4973; author reply 4973–4974.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. POEMS syndrome: Update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2023-09-21
2. Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome;Neurological Sciences;2023-09-13
3. POEMS syndrome: 2021 Update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2021-05-31
4. POEMS Syndrome: 2019 Update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2019-05-23
5. POEMS Syndrome;Neoplastic Diseases of the Blood;2017-09-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3